(S)-LY3177833 hydrate |
| Katalog-Nr.GC65997 |
(S)-LY3177833 ((S)-Beispiel 2)-Hydrat ist ein oral aktiver CDC7-Kinase-Inhibitor. (S)-LY3177833-Hydrat zeigt eine breite In-vitro-AntikrebsaktivitÄt.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2733342-93-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
(S)-LY3177833 ((S)-Example 2) hydrate is an orally active CDC7 kinase inhibitor. (S)-LY3177833 hydrate shows broad in vitro anticancer activity[1].
Review for (S)-LY3177833 hydrate
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for (S)-LY3177833 hydrate
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *